With limited access restrictions, flexible budgets and a high burden of genetic diseases, the GCC region represents significant commercial opportunities for cell and gene therapy manufacturers. Discover the unique regional opportunities and why cell and gene therapy manufacturers are choosing to launch in the GCC ahead of launching in Europe.
Download our latest Snapshot Analysis - The New Frontier of Growth for Cell & Gene Therapies
